Interestingly, Kaplan-Meier survival analysis of cohort clinical GBM specimens suggested that the patients with TRIM21-high and β-catenin-high showed shorter overall survival (OS) and progression-free survival (PFS) as compared with others and TRIM21-low and β-catenin-low group (Figure 7K). Here, TRIM21 is linked to glioblastoma.